Allopregnanolone as a Regenerative Therapeutic for Alzheimer's Disease (AD): A phase 2 proof-of-concept clinical trial using hippocampal volume as a surrogate endpoint

被引：0
|
作者：
Rivera, Gerson Hernandez [1 ]
Lopez, Claudia [1 ]
Raikes, Adam [1 ]
Rodgers, Kathleen [1 ]
Matthews, Dawn [2 ]
Schneider, Lon [3 ]
Brinton, Roberta [1 ]
机构：
[1] Univ Arizona, Ctr Innovat Brain Sci, Tucson, AZ USA
[2] ADM Diagnost, Northbrook, IL USA
[3] USC Sch Med, Los Angeles, CA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202953
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P8-6.008
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Phase 2 Proof-of-concept trial design for BIVV020, a monoclonal antibody targeting complement C1s, in CIDP
    Hughes, Richard
    Lewis, Richard
    Querol, Luis
    Hartung, Hans-Peter
    van Doorn, Pieter
    Wallstroem, Erik
    Luo, Xiaodong
    Alonso-Alonso, Miguel
    Atassi, Nazem
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 355 - 355
  • [42] Evaluation of apremilast in chronic pruritus of unknown origin: A proof-of-concept, phase 2a, open-label, single-arm clinical trial
    Clark, Marie
    Wang, Fang
    Bodet, Nancy D.
    Kim, Brian S.
    HEALTH SCIENCE REPORTS, 2020, 3 (02)
  • [43] A PROOF-OF-CONCEPT, PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF AN HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346)
    Wallace, John
    Buret, Andre
    Vaughan, David
    Muscara, Marcelo
    De Nucci, Gilberto
    Nagy, Peter
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S11 - S12
  • [44] A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease
    Tzimopoulou, Sofia
    Cunningham, Vincent J.
    Nichols, Thomas E.
    Searle, Graham
    Bird, Nick P.
    Mistry, Prafull
    Dixon, Ian J.
    Hallett, William A.
    Whitcher, Brandon
    Brown, Andrew P.
    Zvartau-Hind, Marina
    Lotay, Narinder
    Lai, Robert Y. K.
    Castiglia, Mary
    Jeter, Barbara
    Matthews, Julian C.
    Chen, Kewei
    Bandy, Dan
    Reiman, Eric M.
    Gold, Michael
    Rabiner, Eugenii A.
    Matthews, Paul M.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (04) : 1241 - 1256
  • [45] Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial
    Nanchahal, Jagdeep
    Ball, Catherine
    Davidson, Dominique
    Williams, Lynn
    Sones, William
    McCann, Fiona E.
    Cabrita, Marisa
    Swettenham, Jennifer
    Cahoon, Neil J.
    Copsey, Bethan
    Francis, E. Anne
    Taylor, Peter C.
    Black, Joanna
    Barber, Vicki S.
    Dutton, Susan
    Feldmann, Marc
    Lamb, Sarah E.
    EBIOMEDICINE, 2018, 33 : 282 - 288
  • [46] ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer’s Disease Patients
    Marlies Oosthoek
    A. Lili
    A. Almeida
    O. van Loosbroek
    R. van der Geest
    I. de Greef-van der Sandt
    P. van Bokhoven
    S. A. M. Sikkes
    C. E. Teunissen
    E. G. B. Vijverberg
    The Journal of Prevention of Alzheimer's Disease, 2023, 10 : 669 - 674
  • [47] ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients
    Oosthoek, Marlies
    Lili, A.
    Almeida, A.
    van Loosbroek, O.
    van der Geest, R.
    de Greef-van der Sandt, I.
    van Bokhoven, P.
    Sikkes, S. A. M.
    Teunissen, C. E.
    Vijverberg, E. G. B.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2023, 10 (04): : 669 - 674
  • [48] Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial
    de Freitas, Rubens Moreno
    Susin, Cristiano
    Spin-Neto, Rubens
    Marcantonio, Claudio
    Wikesjoe, Ulf M. E.
    Violin Dias Pereira, Luis Antonio
    Marcantonio, Elcio, Jr.
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2013, 40 (10) : 968 - 975
  • [49] Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial
    Sultzer, David L.
    Davis, Sonia M.
    Tariot, Pierre N.
    Dagerman, Karen S.
    Lebowitz, Barry D.
    Lyketsos, Constantine G.
    Rosenheck, Robert A.
    Hsiao, John K.
    Lieberman, Jeffrey A.
    Schneider, Lon S.
    AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (07): : 844 - 854
  • [50] Comparative clinical study of A1 and A2 subtypes of botulinum toxin preparations for post-stroke spasticity: Proof-of-concept randomized controlled phase 2/3 trial
    Kaji, R.
    Miyashiro, A.
    Furumoto, T.
    Sato, N.
    Sako, W.
    Kaji, S.
    MOVEMENT DISORDERS, 2015, 30 : S552 - S553
12345